🔎 Trials Near Me

Acasă › Leucemie mieloasă acută › Ohio

Studii clinice pentru Leucemie mieloasă acută în Ohio

57 studii pentru Leucemie mieloasă acută caută participanți în Ohio.

Orașe în Ohio

Text oficial al studiului (în engleză)

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

  • Ohio State University Comprehensive Cancer Center, Columbus
În curs de recrutareFaza 2
Vârste de 60 ani și peste · Toate sexele · Actualizat 2 oct. 2026 · NCT07437950

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Summa Health System - Akron Campus, Akron
  • Cleveland Clinic Akron General, Akron
  • Summa Health System - Barberton Campus, Barberton
  • și încă 44
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
Vârste de la 40 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

  • Cincinnati Children's Hospital Medical Center, Cincinnati
În curs de recrutareStudiu observațional
Vârste de la 0 la 38 · Toate sexele · Actualizat 1 oct. 2026 · NCT06131801

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

  • Case Western Reserve University, Cleveland
În curs de recrutareFaza 2
Vârste de la 18 la 59 · Toate sexele · Actualizat 28 sept. 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

  • Gabrail Cancer Center, Canton
  • Miami Valley Hospital South, Centerville
  • Oncology Hematology Care, Cincinnati
  • și încă 2
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT06852222

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • Case Western Reserve University, Cleveland
  • Ohio State University Comprehensive Cancer Center, Columbus
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT05564390

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

  • Ohio State University Comprehensive Cancer Center, Columbus
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 24 sept. 2026 · NCT03874052

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

  • Cincinnati Children's Hospital Medical Center, Cincinnati
În curs de recrutareFaza 1
Până la vârsta de 21 · Toate sexele · Actualizat 23 sept. 2026 · NCT07012044

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

  • Case Western Reserve University, Cleveland
  • Ohio State University Comprehensive Cancer Center, Columbus
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT06317649

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

  • Case Western Reserve University, Cleveland
  • Ohio State University Comprehensive Cancer Center, Columbus
În curs de recrutareFaza 2
Vârste de la 18 la 59 · Toate sexele · Actualizat 22 sept. 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

  • Children's Hospital Medical Center of Akron, Akron
  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Rainbow Babies and Childrens Hospital, Cleveland
  • și încă 4
În curs de recrutareFaza 3
6 Months – 21 Years · Toate sexele · Actualizat 17 sept. 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

  • Ohio State University, Columbus
În curs de recrutareFaza 1/2
30 Days · Toate sexele · Actualizat 16 sept. 2026 · NCT04065399

Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood

  • Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 15 sept. 2026 · NCT06904482

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
În curs de recrutareFaza 1/2
Vârste de 18 ani și peste · Toate sexele · Actualizat 14 sept. 2026 · NCT03471260

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

  • Ohio State University, The James Comprehensive Cancer, Columbus
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 14 sept. 2026 · NCT06846606

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

  • The Ohio Sate University, Columbus
În curs de recrutareFaza 1/2
Vârste de 18 ani și peste · Toate sexele · Actualizat 11 sept. 2026 · NCT06969430

Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

  • Ohio State University Comprehensive Cancer Center, Columbus
În curs de recrutareFaza 1/2
Vârste de la 18 la 75 · Toate sexele · Actualizat 9 sept. 2026 · NCT04049539

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

  • Rainbow Babies and Childrens Hospital, Cleveland
  • ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo
În curs de recrutareFaza 3
Vârste de la 1 la 25 · Toate sexele · Actualizat 4 sept. 2026 · NCT07022678

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

  • University of Cincinnati, Cincinnati
  • OhioHealth Research Institute, Columbus
  • Taylor Cancer Research Center, Maumee
În curs de recrutareStudiu observațional
Vârste de 0 ani și peste · Toate sexele · Actualizat 2 sept. 2026 · NCT07154823

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

  • US-Cincinnati OH-CINCY, Cincinnati
  • US-Colombus OH-OSU, Columbus
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 2 sept. 2026 · NCT06652438

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

  • US-Cincinnati OH-CINCY, Cincinnati
  • US-Colombus OH-OSU, Columbus
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 1 sept. 2026 · NCT07223814

Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy

  • Ohio State University Comprehensive Cancer Center, Columbus
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 27 aug. 2026 · NCT06930352

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

  • Cleveland Clinic, Cleveland
  • Ohio State University, Columbus
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 aug. 2026 · NCT06533761

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • Ohio State University Comprehensive Cancer Center, Columbus
  • University of Cincinnati Cancer Center-West Chester, West Chester
În curs de recrutareFaza 1
Vârste de la 18 la 75 · Toate sexele · Actualizat 25 aug. 2026 · NCT05886049

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Children's Hospital Medical Center of Akron, Akron
  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Rainbow Babies and Childrens Hospital, Cleveland
  • și încă 3
În curs de recrutareFaza 1/2
Până la vârsta de 22 · Toate sexele · Actualizat 25 aug. 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

  • Nationwide Children's Hospital, Columbus
În curs de recrutareFaza 3
29 Days – 21 Years · Toate sexele · Actualizat 24 aug. 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  • Ohio State University, Columbus
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 20 aug. 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  • UH Seidman Cancer Center, Cleveland
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 20 aug. 2026 · NCT06001788

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

  • University Hospitals Cleveland Medical Center, Cleveland
În curs de recrutareFaza 2/3
Vârste de la 18 la 80 · Toate sexele · Actualizat 5 aug. 2026 · NCT06788756

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

  • Cincinnati Children's Hospital Medical Center, Cincinnati
În curs de recrutareFaza 1
Vârste de la 1 la 30 · Toate sexele · Actualizat 3 aug. 2026 · NCT06177067

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

  • University of Cincinnati Medical Center (University Hospital), Cincinnati
  • The Ohio State University Comprehensive Cancer Center (OSUCCC), Cleveland
În curs de recrutareFaza 3
Vârste de la 18 la 75 · Toate sexele · Actualizat 17 iul. 2026 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Childrens Hospital Medical Center of Akron, Akron
  • Cincinnati Children's Hospital, Cincinnati
  • University Hospitals Case Medical Center, Cleveland
  • și încă 3
În curs de recrutareStudiu observațional
Toate vârstele · Toate sexele · Actualizat 6 iul. 2026 · NCT01351545

IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)

  • Ohio State University Comprehensive Cancer Center, Columbus
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 23 iun. 2026 · NCT05401097

Ivosidenib as Post-HSCT Maintenance for AML

  • Ohio State University Wexner Medical Center- James Cancer Hospital, Columbus
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 18 iun. 2026 · NCT06707493

A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)

  • Case Western Reserve University, Cleveland
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 12 iun. 2026 · NCT05834244

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

  • Ohio State University Comprehensive Cancer Center, Columbus
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 14 mai 2026 · NCT06222580

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • University of Cincinnati, Cincinnati
  • The Ohio State University, Columbus
În curs de recrutareFaza 1
Vârste de 13 ani și peste · Toate sexele · Actualizat 5 mai 2026 · NCT04771572

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
În curs de recrutareFaza 2/3
Vârste de 18 ani și peste · Toate sexele · Actualizat 30 apr. 2026 · NCT04256317

Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant

  • Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland
  • University Hospitals Seidman Cancer, Case Comprehensive Cancer Center, Cleveland
În curs de recrutareFaza 1/2
Vârste de 18 ani și peste · Toate sexele · Actualizat 27 apr. 2026 · NCT06129734

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

  • Cincinnati Children's Hospital, Cincinnati
În curs de recrutareFaza 1
Până la vârsta de 21 · Toate sexele · Actualizat 22 apr. 2026 · NCT05101551

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.